Drawing for XXS GENES

USPTO serial 78370460

XXS GENES

Reviewed by CopyMark Law Group

Reg. 3473606Status 710
Filing date
Status date
Registration date
Jul 22, 2008
Examiner
GAST, PAUL
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with XXS GENES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Bacteria for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds, bacteriological preparations for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; micro-organism cultures for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; biochemical catalysts for use in food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of pharmaceutical compounds; biological preparations for clinical, research and medical laboratory use, namely, proteins, DNA, RNA and modifications thereof; diagnostic preparations for research use, namely, proteins, DNA, RNA and modifications thereof; and enzymes and enzyme preparations for use in the field of food manufacture, waste water treatment, fermentation, pharmaceutical research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compoundsSECTION 8 - CANCELLEDApr 3, 2008
005Medicines for human medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; medicines for dental purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; medicines for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; bacteriological preparations for medical and veterinary purposes, for use in the treatment of cancer, high blood pressure, diarrhea, skin irritations, infections, diabetes, autoimmune diseases and arthritis, as well as for use in gene therapy; biological preparations for medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes, for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; biological preparations for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones, and enzymes for use in the treatment of cancer, diabetes, Alzheimer's disease and infectious diseases; germicides for institutional use, and domestic uses; vermicides for institutional use, domestic use, and residential uses; fungicides for institutional use, and domestic uses; biological materials for medical diagnostic laboratories, namely, proteins, DNA, RNA and modifications thereof; diagnostic materials for clinical and medical laboratory purposes, namely, proteins, DNA, RNA and modifications thereof; deoxyribonucleic acid, especially deoxyribonucleic acid comprising 80 to 150 base pairs; and genes, especially genes comprising 80 to 150 base pairsSECTION 8 - CANCELLEDApr 3, 2008

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 10, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 10, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 10, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 10, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 10, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 27, 2015C8..CANCELLED SEC. 8 (6-YR)
Jul 23, 2014ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 23, 2014REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 21, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 21, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 2, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 2, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 1, 2011TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 12, 2008TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 22, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 16, 2008REGVLAW OFFICE REGISTRATION REVIEW COMPLETED
Jun 16, 2008ALIEASSIGNED TO LIE
Jun 16, 2008CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 2, 2008SUPCSTATEMENT OF USE PROCESSING COMPLETE
Jun 2, 2008EX5GSOU EXTENSION 5 GRANTED
May 20, 2008IUAFUSE AMENDMENT FILED
May 20, 2008EXT5SOU EXTENSION 5 FILED
May 20, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 20, 2008EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 28, 2007EX4GSOU EXTENSION 4 GRANTED
Nov 28, 2007EXT4SOU EXTENSION 4 FILED
Nov 28, 2007EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 18, 2007ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jun 12, 2007EX3GSOU EXTENSION 3 GRANTED
Jun 12, 2007EXT3SOU EXTENSION 3 FILED
Jun 12, 2007EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 7, 2007ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 19, 2006EX2GSOU EXTENSION 2 GRANTED
Dec 19, 2006EXT2SOU EXTENSION 2 FILED
Dec 19, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 13, 2006EX1GSOU EXTENSION 1 GRANTED
Jun 13, 2006EXT1SOU EXTENSION 1 FILED
Jun 13, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 20, 2005NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 27, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 7, 2005NPUBNOTICE OF PUBLICATION
Jul 14, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 8, 2005ALIEASSIGNED TO LIE
Jul 7, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jul 7, 2005ACECAMENDMENT FROM APPLICANT ENTERED
Jul 5, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 5, 2005FAXXFAX RECEIVED
Jun 23, 2005GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 2, 2005ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN
May 27, 2005CWBPWITHDRAWN BEFORE PUBLICATION
Mar 3, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 14, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Feb 8, 2005ACECAMENDMENT FROM APPLICANT ENTERED
Feb 8, 2005ALIEASSIGNED TO LIE
Jan 18, 2005CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 18, 2005MAILPAPER RECEIVED
Sep 30, 2004GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2004CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 9, 2004DOCKASSIGNED TO EXAMINER
Mar 4, 2004NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance